Feed BAX
BA

Baxter International

BAX · NYSE

$24.36 +1.92% (+$0.46)
1M +2.05%
Market Cap $12.6B
P/E Ratio -
Div. Yield 0.16%
ROE 16.60%

Bulios Fair Price

$13.65

44.0% downside

Trenutna cena

$24.36

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BAX trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Moderate
4/9
Valuation
53 /100
Fair
P/B 2.03x
EV/EBITDA 26.81x
P/FCF 18.58x
Growth
24 /100
Declining
Book val. growth 1.66%
Rev. growth 3.79%
FCF growth 17.54%
Profitability
24 /100
Weak
Op. margin 2.39%
Gross margin 30.08%
FCF margin 5.91%
Quality
7 /100
Poor
ROA 5.37%
ROIC 3.22%
Asset turnover 0.58x
Debt
24 /100
High
Int. coverage -0.70x
Debt/Equity 1.56x
Net debt/EBITDA 10.02x
Stability
56 /100
Moderate
EPS volatility 172.55%
Beta 0.65x
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BAX
Online

O podjetju

Baxter International Inc. (BAX) is an American healthcare company specializing in the development, manufacture, and distribution of medical devices, pharmaceutical products, and biological therapies. With a broad portfolio of products focused on the care of patients with hemophilia, kidney diseases, immune disorders, and other serious health conditions, Baxter is one of the leading players in the healthcare industry. The company is known for its emphasis on innovation and quality, enabling it to provide top-notch solutions to improve the health and quality of life of patients. Baxter International also invests in research and development of new treatment methods and technologies. Baxter International Inc. (BAX) shares could be suitable for investors looking for opportunities in the healthcare sector with a focus on innovation and a broad therapeutic portfolio.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Andrew Hider

Employees

37,500

Headquarters

Deerfield

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

17d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.